TrialInternational journal of clinical oncology2019

Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).

Toshikazu Moriwaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.